The global newborn screening market was valued at USD 789.35 million in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.54% from 2023 to 2030. Key factors expected to drive this growth include the increasing neonatal population, a rising incidence of congenital diseases in newborns, greater consumer awareness, and supportive initiatives and programs from...